Showing results (21-30 of 140) with videos related to

Sort By:
Pageof 14
Journal of Neurology|March 14, 2019
Efficacy and safety of alemtuzumab in a real-life cohort of patients with multiple sclerosisJessica Frau, Giancarlo Coghe, Lorena Lorefice, et al.
Frontiers in Genetics|February 16, 2023
Omics approaches to understanding the efficacy and safety of disease-modifying treatments in multiple sclerosisLorena Lorefice, Maristella Pitzalis, Federica Murgia, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|March 13, 2024
Ocrelizumab use in multiple sclerosis: a real-world experience in a changing therapeutic scenarioLorena Lorefice, Paolo Mellino, Jessica Frau, et al.
BMJ Supportive & Palliative Care|June 26, 2017
The burden of multiple sclerosis and patients' coping strategiesLorena Lorefice, Giuseppe Fenu, Jessica Frau, et al.
Work (Reading, Mass.)|February 6, 2018
The impact of visible and invisible symptoms on employment status, work and social functioning in Multiple SclerosisLorena Lorefice, Giuseppe Fenu, Jessica Frau, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|October 19, 2022
Change in upper limb function in people with multiple sclerosis treated with nabiximols: a quantitative kinematic pilot studyMassimiliano Pau, Micaela Porta, Gabriella Spinicci, et al.
Multiple Sclerosis and Related Disorders|January 24, 2018
Pulse steroid therapy in multiple sclerosis and mood changes: An exploratory prospective studyLorena Lorefice, Giuseppe Fenu, Michela Fois, et al.
Diabetes|October 16, 2007
Further evidence of a primary, causal association of the PTPN22 620W variant with type 1 diabetesMagdalena Zoledziewska, Chiara Perra, Valeria Orrù, et al.
The International Journal of Biochemistry & Cell Biology|July 20, 2017
Metabolomic analysis identifies altered metabolic pathways in Multiple SclerosisSimone Poddighe, Federica Murgia, Lorena Lorefice, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 29, 2017
Localized pigmentation disorder after subcutaneous pegylated interferon beta-1a injectionGiancarlo Coghe, Laura Atzori, Jessica Frau, et al.
Pageof 14